Cardiology

Ongoing Projects

Sponsor	Protocol Code	Trial Name	Principal Investigator	Phase	Therapeutic Area	Diseases and Conditions
Taewoong Medical Co.	TWTPV-E1001	PULSTA™ Transcatheter Pulmonary Valve (TPV) Pre-approval Study	ENDER ÖDEMİŞ (Prof.Dr.)	Medical Device	Cardiology	Valvular Heart Disease
Novartis	CKJX839D12302	A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients	DİLEK URAL (Prof.Dr.)	Phase 3	Cardiology	Cardiovascular Diseases
AstraZeneca	D7960C00015	A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event	DİLEK URAL (Prof.Dr.)	Phase 3	Cardiology	Cardiovascular Diseases
Anthos Therapeutics	ANT-010	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Abelacimab in High-risk Patients with Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation (LILAC)	EROL TÜLÜMEN (Prof.Dr.)	Phase 3	Cardiology	Cardiac Arrhythmias